A January acquisition deal between medical technology provider Hillrom and cardiac monitoring device maker Bardy Diagnostics has landed in rocky waters, with Hillrom looking to back out of the purchase and Bardy filing a legal complaint to keep things moving forward.
According to press releases from Hillrom, the company was caught off guard on January 29 when Novitas Solutions, a Medicare...
Cardiac-monitoring device maker Bardy Diagnostics has agreed to an acquisition by Hillrom, a medical technology provider specializing in smart hospital beds and other connected monitoring tools. The $375 million deal is expected to close during fiscal Q2 2021.
Bardy's flagship product is the Carnation Ambulatory Monitor, often referred to as the CAM patch. It's a P-wave signal-capturing wearable...
Bardy Diagnostics, maker of cardiac-monitoring adhesive patches, announced yesterday that Kevin Hykes began serving as the company's president and CEO on August 31. Hykes was formerly the president and CEO of Relievant Medical Systems, Metaventon and Cameron Health. Earlier in his career he spent 16 years at Medtronic. As Bardy Diagnostics' new head, he'll help develop and execute the company's...
The Digital Therapeutics Alliance, an industry group advocating for the adoption and understanding of evidence-based digital health treatments, has named its new Board of Directors. Representing handful of different digital therapeutics stakeholders, those named are set to hold their positions for a two-year period.
Along with Megan Coder, the group’s executive director, the board consists of:...
Bardy Diagnostics, maker of an adhesive ambulatory cardiac patch for remote monitoring, has raised $35.5 million in a Series B funding round led by River Cities Capital Funds. The round also featured participation from newcomers HealthQuest Capital, Aperture Venture Partners, Aphelion Capital, Lumira Ventures and Rex Health Ventures, as well as returning backers SV Health Investors, Health...
